Cite
HARVARD Citation
Harbeck, N. et al. (2020). Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7). Therapeutic advances in medical oncology. p. . [Online].